![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1133378-37-6
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | Darunavir-d9 REF: 4Z-D-372CAS: 1133378-37-6 | - - - | A consultar | Mar 04 Mar 25 |
![]() | Darunavir-d9 (iso-butyl-d9)(Darunavir) REF: 3U-D7573CAS: 1133378-37-6 | 99 atom % D | 1.413,00 €~2.400,00 € | Lun 03 Mar 25 |
![]() | Darunavir-d9 REF: TR-D193502CAS: 1133378-37-6 | - - - | 465,00 €~3.260,00 € | Mar 11 Mar 25 |
![]() | Darunavir-D9 REF: 3D-IVB37837CAS: 1133378-37-6 | Min. 95% | A consultar | Lun 14 Abr 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Darunavir-d9
CAS:1133378-37-6
Fórmula:
C27H28D9N3O7S
Forma y color:
White To Off-White Solid
Peso molecular:
556.72
Ref: 4Z-D-372
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 3U-D7573
5mg | 1.413,00 € | ||
10mg | 2.400,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Darunavir-d9
Producto controladoCAS:1133378-37-6
Applications Second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. It is a COVID19-related research …
Fórmula:
C27H9H28N3O7S
Forma y color:
Off-White To Light Beige
Peso molecular:
556.72
Ref: TR-D193502
1mg | 465,00 € | ||
10mg | 3.260,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Darunavir-D9
CAS:1133378-37-6
Darunavir-D9 is a prodrug of darunavir, which is an HIV protease inhibitor. Darunavir-D9 has been …
Fórmula:
C27H28D9N3O7S
Pureza:
Min. 95%
Peso molecular:
556.72 g/mol
Ref: 3D-IVB37837
5mg | 1.628,00 € | ||
10mg | 2.504,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025